---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-276208"
form_type: "8-K"
ticker: "HNGE"
cik: "0001673743"
company_name: "Hinge Health, Inc."
filed_at: "2025-11-12T23:59:59+00:00"
generated_at: "2026-05-16T21:17:40.731197+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Hinge Health authorizes $250M share repurchase; Q3 free cash flow $118M

## Summary
- Board approved up to $250M repurchase of Class A common stock on Nov 10, 2025.
- Q3 2025 cash from operations $108M, free cash flow $118M; cash and investments ~$500M.
- Repurchases may be made in open market or private transactions; no minimum obligation.
- Company expects to fund repurchases with existing cash and cash from operations.
- Buyback may be modified, suspended, or terminated at any time at board's discretion.

## SEC filing metadata
- accession: 0001193125-25-276208
- form_type: 8-K
- ticker: HNGE
- cik: 0001673743
- company_name: Hinge Health, Inc.
- filed_at: 2025-11-12T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1673743/000119312525276208/0001193125-25-276208-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1673743/000119312525276208/hnge-20251110.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-276208
- JSON: https://secwatch.observer/filing/0001193125-25-276208.json
- Plain text: https://secwatch.observer/filing/0001193125-25-276208.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.